Attenuation of Cystitis and Pain Sensation in Mice Lacking Fatty Acid Amide Hydrolase

Journal of Molecular Neuroscience

Volumn 55, Issue 4, 2015, Pages 968-976

  Wang, Zun Yi ^a   Wang, Peiqing ^a   Hillard, Cecilia J ^b   Bjorling, Dale E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cystitis; Fatty acid amide hydrolase; Mice; N arachidonoylethanolamine; Pain

Indexed keywords

ANANDAMIDE; CYCLOOXYGENASE 2; CYCLOPHOSPHAMIDE; ENDOCANNABINOID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID AMIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MESSENGER RNA; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; AMIDASE; AMIDE; ARACHIDONIC ACID DERIVATIVE; CYTOKINE; FATTY-ACID AMIDE HYDROLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER FUNCTION; BLADDER MUCOSA; CELL INFILTRATION; CONTROLLED STUDY; CYSTITIS; ENZYME DEGRADATION; GENE EXPRESSION; GENOTYPE; HYPERALGESIA; INFLAMMATORY CELL; MALE; MICTURITION; MOUSE; NOCICEPTION; NONHUMAN; ANIMAL; BLADDER; C57BL MOUSE; GENETICS; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; CYSTITIS; CYTOKINES; ENDOCANNABINOIDS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; NOCICEPTION; POLYUNSATURATED ALKAMIDES; RNA, MESSENGER; URINARY BLADDER;

EID: 84925538196     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-014-0453-x     Document Type: Article

References (61)

1. Ahn K, Johnson DS, Mileni M, Beidler D, Long JZ, McKinney MK, Weerapana E, Sadagopan N, Liimatta M, Smith SE, Lazerwith S, Stiff C, Kamtekar S, Bhattacharya K, Zhang Y, Swaney S, Van Becelaere K, Stevens RC, Cravatt BF (2009) Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem Biol 16:411–420
2. Aizawa N, Hedlund P, Füllhase C, Ito H, Homma Y, Igawa Y (2014) Inhibition of peripheral FAAH depresses activities of bladder mechanosensitive Nerve Fibers of the Rat. J Urol
3. Alvarez-Jaimes LJ, Palmer JA (2011) The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation. Curr Pharm Biotechnol 12:1644–1659
4. Anderson WB, Gould MJ, Torres RD, Mitchell VA, Vaughan CW (2014) Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model. Neuropharmacology 81:224–230
5. Birder L, Andersson KE (2013) Urothelial signaling. Physiol Rev 93:653–680
6. Birder LA, Nakamura Y, Kiss S, Nealen ML, Barrick S, Kanai AJ, Wang E, Ruiz G, De Groat WC, Apodaca G, Watkins S, Caterina MJ (2002) Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 5:856–860
7. Bisogno T, Maccarrone M (2013) Latest advances in the discovery of fatty acid amide hydrolase inhibitors. Expert Opin Drug Discov 8:509–522
8. Bjorling DE, Jerde TJ, Zine MJ, Busser BW, Saban MR, Saban R (1999) Mast cells mediate the severity of experimental cystitis in mice. J Urol 162:231–236
9. Bjorling DE, Elkahwaji JE, Bushman W, Janda LM, Boldon K, Hopkins WJ, Wang ZY (2007) Acute acrolein-induced cystitis in mice. BJU Int 99:1523–1529
10. Bjorling DE, Wang ZY, Bushman W (2011) Models of inflammation of the lower urinary tract. Neurourol Urodyn 30:673–682
11. Blankman JL, Cravatt BF (2013) Chemical probes of endocannabinoid metabolism. Pharmacol 65:849–871
12. Cencioni MT, Chiurchiù V, Catanzaro G, Borsellino G, Bernardi G, Battistini L, Maccarrone M (2010) Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS One 5:e8688
13. Cervero F, Laird JM (2004) Understanding the signaling and transmission of visceral nociceptive events. J Neurobiol 61:45–54
14. Chang L, Luo L, Palmer JA, Sutton S, Wilson SJ, Barbier AJ, Breitenbucher JG, Chaplan SR, Webb M (2006) Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. Br J Pharmacol 148:102–113
15. Clapper JR, Moreno-Sanz G, Russo R, Guijarro A, Vacondio F, Duranti A, Tontini A, Sanchini S, Sciolino NR, Spradley JM, Hohmann AG, Calignano A, Mor M, Tarzia G, Piomelli D (2010) Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. Nat Neurosci 13:1265–1270
16. Conklin DJ, Haberzettl P, Lesgards JF, Prough RA, Srivastava S, Bhatnagar A (2009) Increased sensitivity of glutathione S-transferase Pnull mice to cyclophosphamide-induced urinary bladder toxicity. J Pharmacol Exp Ther 331:456–469
17. Cornelissen LL, Misajet B, Brooks DP, Hicks A (2008) Influence of genetic background and gender on bladder function in the mouse. Auton Neurosci 140:53–58
18. Cravatt BF, Lichtman AH (2003) Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol 7:469–475
19. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 98:9371–9376
20. D’Argenio G, Valenti M, Scaglione G, Cosenza V, Sorrentini I, Di Marzo V (2006) Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. FASEB J 20:568–570
21. Daly DM, Collins VM, Chapple CR, Grundy D (2011) The afferent system and its role in lower urinary tract dysfunction. Curr Opin Urol 21:268–274
22. Dinis P, Charrua A, Avelino A, Yaqoob M, Bevan S, Nagy I, Cruz F (2004) Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. J Neurosci 24:11253–11263
23. Füllhase C, Russo A, Castiglione F, Benigni F, Campeau L, Montorsi F, Gratzke C, Bettiga A, Stief C, Andersson KE, Hedlund P (2013) Spinal cord FAAH in normal micturition control and bladder overactivity in awake rats. J Urol 189:2364–2370
24. Gandaglia G, Strittmatter F, La Croce G, Benigni F, Bettiga A, Castiglione F, Moschini M, Mistretta F, Gratzke C, Montorsi F, Stief C, Hedlund P (2013) The fatty acid amide hydrolase inhibitor oleoyl ethyl amide counteracts bladder overactivity in female rats. Neurourol Urodyn
25. Gonzalez EJ, Merrill L, Vizzard MA (2014) Bladder sensory physiology: neuroactive compounds and receptors, sensory transducers, and target-derived growth factors as targets to improve function. Am J Physiol Regul Integr Comp Physiol 306:R869–R878
26. Gratzke C, Streng T, Park A, Christ G, Stief CG, Hedlund P, Andersson KE (2009) Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. J Urol 181:1939–1948
27. Gratzke C, Streng T, Stief CG, Downs TR, Alroy I, Rosenbaum JS, Andersson KE, Hedlund P (2010) Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats. Eur Urol 57:1093–1100
28. Hedlund P (2014) Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction. Neurourol Urodyn 33:46–53
29. Hill WG. Control of urinary drainage and voiding (2014) Clin J Am Soc Nephrol
30. Hillard CJ, Manna S, Greenberg MJ, DiCamelli R, Ross RA, Stevenson LA, Murphy V, Pertwee RG, Campbell WB (1999) Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther 289:1427–1433
31. Jayamanne A, Greenwood R, Mitchell VA, Aslan S, Piomelli D, Vaughan CW (2006) Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br J Pharmacol 147:281–288
32. Keay SK, Birder LA, Chai TC (2014) Evidence for bladder urothelial pathophysiology in functional bladder disorders. Biomed Res Int
33. Kinsey SG, Naidu PS, Cravatt BF, Dudley DT, Lichtman AH (2011) Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice. Pharmacol Biochem Behav 99:718–725
34. Klinger MB, Dattilio A, Vizzard MA (2007) Expression of cyclooxygenase-2 in urinary bladder in rats with cyclophosphamide-induced cystitis. Am J Physiol Regul Integr Comp Physiol 293:R677–R685
35. Krishnan G, Chatterjee N (2012) Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation. Glia 60:1629–1645
36. Lichtman AH, Shelton CC, Advani T, Cravatt BF (2004) Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain 109:319–327
37. Maione S, Costa B, Di Marzo V (2013) Endocannabinoids: a unique opportunity to develop multitarget analgesics. Pain 154:S87–S93
38. Malley SE, Vizzard MA (2002) Changes in urinary bladder cytokine mRNA and protein after cyclophosphamide-induced cystitis. Physiol Genomics 9:5–13
39. Massa F, Marsicano G, Hermann H, Cannich A, Monory K, Cravatt BF, Ferri GL, Sibaev A, Storr M, Lutz B (2004) The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest 113:1202–1209
40. Merriam FV, Wang ZY, Hillard CJ, Stuhr KL, Bjorling DE (2011) Inhibition of fatty acid amide hydrolase suppresses referred hyperalgesia induced by bladder inflammation. BJU Int 108:1145–1149
41. Merrill L, Malley S, Vizzard MA (2013) Repeated variate stress in male rats induces increased voiding frequency, somatic sensitivity, and urinary bladder nerve growth factor expression. Am J Physiol Regul Integr Comp Physiol 305:R147–56
42. Patel S, Rademacher DJ, Hillard CJ (2003) Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. J Pharmacol Exp Ther 306:880–888
43. Salaga M, Mokrowiecka A, Zakrzewski PK, Cygankiewicz A, Leishman E, Sobczak M, Zatorski H, Małecka-Panas E, Kordek R, Storr M, Krajewska WM, Bradshaw HB, Fichna J (2014)a Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH). J Crohns Colitis
44. Salaga M, Sobczak M, Fichna J (2014)b Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract. Eur J Pharm Sci
45. Schlosburg JE, Kinsey SG, Lichtman AH (2009) Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation. AAPS J 11:39–44
46. Schrepf A, O’Donnell M, Luo Y, Bradley CS, Kreder K, Lutgendorf S (2014) Inflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: associations with painful symptoms. Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network. Pain
47. Selo-Ojeme DO, Onwude JL (2004) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Interstitial cystitis. J Obstet Gynaecol 24:216–225
48. Stanford EJ, Dell JR, Parsons CL (2007) The emerging presence of interstitial cystitis in gynecologic patients with chronic pelvic pain. Urology 69:53–59
49. Storr MA, Keenan CM, Emmerdinger D, Zhang H, Yüce B, Sibaev A, Massa F, Buckley NE, Lutz B, Göke B, Brand S, Patel KD, Sharkey KA (2008) Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors. J Mol Med (Berl) 86:925–936
50. Storr MA, Keenan CM, Zhang H, Patel KD, Makriyannis A, Sharkey KA (2009) Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. Inflamm Bowel Dis 15:1678–1685
51. Strittmatter F, Gandaglia G, Benigni F, Bettiga A, Rigatti P, Montorsi F, Gratzke C, Stief C, Colciago G, Hedlund P (2012) Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats. Eur Urol 61:98–106
52. Tambaro S, Casu MA, Mastinu A, Lazzari P (2014) Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. Eur J Pharmacol
53. Tripp DA, Nickel JC, Wong J, Pontari M, Moldwin R, Mayer R, Carr LK, Doggweiler R, Yang CC, Mishra N, Nordling J (2012) Mapping of pain phenotypes in female patients with bladder pain syndrome/interstitial cystitis and controls. Eur Urol 62:1188–1194
54. Tyagi V, Philips BJ, Su R, Smaldone MC, Erickson VL, Chancellor MB, Yoshimura N, Tyagi P (2009) Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium. J Urol 181:1932–1938
55. van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, Elneil S, Fall M, Hohlbrugger G, Irwin P, Mortensen S, van Ophoven A, Osborne JL, Peeker R, Richter B, Riedl C, Sairanen J, Tinzl M, Wyndaele JJ (2008) Visceral pain is the most debilitating symptom of painful bladder syndrome. Eur Urol 53:60–67
56. 1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents. Mol Pain 7:31
57. Wang ZY, Wang P, Merriam FV, Bjorling DE (2008) Lack of TRPV1 inhibits cystitis-induced increased mechanical sensitivity in mice. Pain 139:158–167
58. Wang ZY, Wang P, Bjorling DE (2009) Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells. Am J Physiol Regul Integr Comp Physiol 297:R1127–R1135
59. Wang ZY, Wang P, Bjorling DE (2013) Activation of cannabinoid receptor 2 inhibits experimental cystitis. Am J Physiol Regul Integr Comp Physiol 304:R846–R853
60. Wang ZY, Wang P, Bjorling DE (2014) Treatment with a cannabinoid receptor 2 agonist decreases severity of established cystitis. J Urol 191:1153–1158
61. Wise LE, Cannavacciulo R, Cravatt BF, Martin BF, Lichtman AH (2007) Evaluation of fatty acid amides in the carrageenan-induced paw edema model. Neuropharmacology 54:181–188